Rayont Inc.

RAYT

US75508M1009

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 08:39:38 30/04/2024 pm IST			5-day change	1st Jan Change
0.1 ^USD	+19,900.00%		-.--%	-.--%

2023	Rayont Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	CI
2023	Rayont Inc. Announces Board Appointments	CI

A & C United Agriculture Developing Inc. has Changed its Name to Velt International Group Inc

September 13, 2017 at 09:30 am IST

On September 13, 2017, A & C United Agriculture Developing Inc. changed its name to Velt International Group Inc.

Latest news about Rayont Inc.

Rayont Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	15/23/15	CI
Rayont Inc. Announces Board Appointments	25/23/25	CI
Rayont Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	15/23/15	CI
Rayont Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	17/23/17	CI
Rayont Inc. Reports Earnings Results for the Full Year Ended June 30, 2022	29/22/29	CI
Rayont Inc. Auditor Raises 'Going Concern' Doubt	29/22/29	CI
Rayont Inc. Appoints Ilenna Copley as Chief Operating Officer	20/22/20	CI
Rayont Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	18/22/18	CI
Rayont Inc. Announces Management Changes	25/22/25	CI
Rayont Inc. Announces Board Resignations	23/22/23	CI
Rayont Inc. Announces Management Changes	02/22/02	CI
Rayont Inc. Announces Executive Changes	02/22/02	CI
Rayont Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	24/22/24	CI
Rayont Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021	15/21/15	CI
Rayont, Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2021	17/21/17	CI
Rayont Inc. Appoints Leilani Latimer as Non-Executive Director	22/21/22	CI
Rayont, Inc. Announces Appointment of Dhurata Toli as Secretary	26/21/26	CI
Rayont Inc Announces Executive Changes	25/21/25	CI
Rayont, Inc. Announces Management Changes	25/21/25	CI
Rayont Inc Appoints Reyad Fezzani as Non-Executive Director and Chairman of the Board	15/21/15	CI
Rayont, Inc. Changes its Fiscal Year End from July 31 to June 30	04/21/04	CI
Rayont : Earnings Flash (RAYT) RAYONT Reports Q4 Revenue $457,865	16/21/16	MT
Rayont, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2020	16/21/16	CI
Rayont, Inc. Announces Fiscal Year Change from September 30 to June 30, Effective December 21, 2020	22/20/22	CI
Rayont, Inc. Reports Earnings Results for the Full Year Ended September 30, 2020	18/20/18	CI

Rayont Inc. operates in the personalized natural healthcare sector in United States and Australia. The Company uses scientific tools, such as deoxyribonucleic acid (DNA), microbiome, iridology and other tests to diagnose and personalize the prescription of natural complementary medicine products, services and treatments to its patients in the markets the Company operate. The Company produces a range of products, including proteins, green blends, sports nutrition, weight management and maintenance, and health and wellness products. The Company's subsidiaries include Rayont (Malaysia) Sdn Bhd, Rayont International (L) Limited, Rayont (Australia) Pty Ltd and Prema Life (USA) Inc.

Sector

Biotechnology & Medical Research

Calendar

14/10/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
RAYONT INC.	-.--%	45.74L
MODERNA, INC.	+40.80%	5.37TCr
LONZA GROUP AG	+35.79%	3.89TCr
IQVIA HOLDINGS INC.	-8.05%	3.88TCr
CELLTRION, INC.	-8.98%	2.73TCr
ICON PUBLIC LIMITED COMPANY	+10.69%	2.59TCr
ALNYLAM PHARMACEUTICALS, INC.	-16.21%	2.03TCr
UNITED THERAPEUTICS CORPORATION	+31.00%	1.28TCr
MEDPACE HOLDINGS, INC.	+28.51%	1.22TCr
BIO-TECHNE CORPORATION	-1.67%	1.2TCr